Ark Global Emerging Companies, LP
Style: Emerging Markets Small Cap
Objective: Seeks to achieve high risk-adjusted returns in emerging markets, with a focus on small cap equities.
Inception: 1/1/2018
Total Strategy Assets: $65,775,544 of 12/31/2024
Fund Managers
Spencer co-founded Seven Canyons in 2017. He is a portfolio manager for AEC, WASIX, and WAGTX. Prior to Seven Canyons, Spencer was a Portfolio Manager at Grandeur Peak Funds. He managed The Grandeur Peak Emerging Markets Opportunities Fund (GPEIX) and co-managed The Grandeur Peak International Opportunities (GPIOX) and The Grandeur Peak Global Reach (GPROX) funds. Before Grandeur, Spencer worked at Sidoti & Company and Wasatch Advisors.
Andrey joined Seven Canyons in February 2020 as a portfolio manager for AEC, WASIX, and WAGTX. Before Seven Canyons, Andrey was Portfolio Manager and Senior Analyst at Wasatch Advisors. At Wasatch Advisors, he co-managed the Wasatch Emerging Markets Small Cap fund. Andrey is also a CFA charter holder and has worked as a CPA for Deloitte audit practice. He has an MBA and a Masters of Accounting from University of Wisconsin – Madison.
Year To Date & Annualized Returns
MSCI Emerging Markets Small Cap (benchmark) - The index measures the performance of the small cap segments of emerging market equity securities, which tends to capture more local economic and sector characteristics relative to larger emerging markets capitalization segments. It is free float-adjusted market-capitalization weighted
Performance
| As of 12/31/2024 | 1 Month | QTD | YTD | 1 Year | 3 Year Ann. | 5 Year Ann. | ITD |
|---|---|---|---|---|---|---|---|
| AEC | -0.71% | -3.75% | 0.78% | 0.78% | -0.31% | 12.84% | 9.35% | MSCI Emerging Markets Small Cap Index | -1.02% | -7.20% | 4.80% | 4.80% | 2.11% | 8.56% | 4.59% |
| As of 12/31/2024 | 1 Month | QTD | YTD | 1 Year | 3 Year Ann. | 5 Year Ann. | ITD |
|---|---|---|---|---|---|---|---|
| AEC | -0.71% | -3.75% | 0.78% | 0.78% | -0.31% | 12.84% | 9.35% | MSCI Emerging Markets Small Cap Index | -1.02% | -7.20% | 12.76% | 4.80% | 4.80% | 8.56% | 4.59% |
| Calendar Year Performance | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| AEC | 0.78% | 26.87% | -22.52% | 32.16% | 39.75% | 14.88% | MSCI Emerging Markets Small Cap Index | 4.80% | 23.92% | -17.95% | 18.76% | 19.29% | 11.51% | MSCI Emerging Markets Index | 7.77% | 9.83% | -20.09% | -2.54% | 18.31% | 18.42% |
Past performance is not indicative of future performance. Current performance numbers can be lower or higher than the return data displayed. Performance under one year is annualized, and all performance returns are net of the Fund’s management fees, applicable high water mark fees, and Fund expenses. Seven Canyons Advisors, LLC is the Fund’s investment adviser and absorbs most Fund expenses except for periodic trading costs.
Investing in private placement securities such as this offering, is speculative and involves a risk of loss. Returns are not guaranteed.
Limited Partnership
Minimum Investment: $1,000,000
Separate Account
Minimum Investment: $50,000,000
Top 10 Holdings
| As of 12/31/2024 | % Portfolio Weight | 3B BLACKBIO DX | 7.85% | GENOMMA LAB-B | 5.19% | TIME TECHNOPLAST | 4.59% | MEDIKALOKA HERMI | 4.21% | SUPREMA INC | 3.14% | IFIRMA SA | 3.13% | MIDI UTAMA INDON | 2.42% | ZILLTEK TECHNOLO | 2.18% | PHILIPP SEVEN | 2.16% | BLISS GVS PHARMA | 2.15% |
|---|